Investors & Media International Stem Cell Corporation Announces Record Sales and Operating Results for the Three and Six-Months ended June 30, 2018 International Stem Cell Corporation Developed 3D Liver Structures International Stem Cell Corporation Expands Manufacturing Capabilities for Biomedical Products International Stem Cell Corporation Publishes Advanced Stem Cell Therapy Methodology in Stem Cells and Development Journal International Stem Cell Corporation Doses First Patient of the Third Cohort in Parkinson's Disease Clinical Trial International Stem Cell Corporation to Launch Advanced Joint Supplement International Stem Cell Corporation Published Technology for Cartilage Generation in Journal of Tissue Engineering and Regenerative Medicine Technology International Stem Cell Corporation Announces Operating Results for the Quarter Ended March 31, 2018 International Stem Cell Corporation is Valued at $34 Million Market Value by Edison Investment Research International Stem Cell Corporation Granted Key Patent in US 1 2 3 4 5 6 7 8 << < > >>
